New Reports by EMR Analyze the Potential of Hypertension Drug Market of Several Key Countries

EMR's new series of reports provide deep insight into a number of developed and emerging markets for Hypertension drugs

Noida, India (prHWY.com) September 1, 2011 - In its new series of reports on Hypertension, Expert Market Research, one of the world's leading providers of lifeScience market intelligence, analyses the market potential of Hypertension drugs in several key countries.

EMR's Hypertension market series includes the following reports:

* UK Hypertension Market Report and Forecast: 2011-2016
* France Hypertension Market Report and Forecast: 2011-2016
* Italy Hypertension Market Report and Forecast: 2011-2016
* Spain Hypertension Market Report and Forecast: 2011-2016
* Germany Hypertension Market Report and Forecast: 2011-2016
* Vietnam Hypertension Market Report and Forecast: 2011-2016
* Egypt Hypertension Market Report and Forecast: 2011-2016
* Indonesia Hypertension Market Report and Forecast: 2011-2016
* Saudi Arabia Hypertension Market Report and Forecast: 2011-2016
* South Africa Hypertension Market Report and Forecast: 2011-2016
* Argentina Hypertension Market Report and Forecast: 2011-2016
* Thailand Hypertension Market Report and Forecast: 2011-2016
* South Korea Hypertension Market Report and Forecast: 2011-2016
* Turkey Hypertension Market Report and Forecast: 2011-2016
* Mexico Hypertension Market Report and Forecast: 2011-2016
* China Hypertension Market Report and Forecast: 2011-2016
* India Hypertension Market Report and Forecast: 2011-2016
* Russia Hypertension Market Report and Forecast: 2011-2016
* Brazil Hypertension Market Report and Forecast: 2011-2016
* Canada Hypertension Market Report and Forecast: 2011-2016
* Greece Hypertension Market Report and Forecast: 2011-2016
* Australia Hypertension Market Report and Forecast: 2011-2016
* Japan Hypertension Market Report and Forecast: 2011-2016
* US Hypertension Market Report and Forecast: 2011-2016

Each of these reports provides a comprehensive analysis on the current and future market trends in the hypertension drugs market. These reports also facilitates a deep insight into the current and future epidemiology of hypertension and its market structure besides probing into the performance of various therapeutic classes, companies, molecules and brands. These reports can serve as an excellent guide for clients who are in need of an in-depth understanding of the market for hypertension drugs.

Key Questions Answered in this Report:
* What are the current and future prevalence rates for hypertension?
* What is the current and future size of the hypertension patient population?
* What has been the historical performance of the hypertension market and how will it behave in the coming years?
* Who are the leading companies in the hypertension market and how will they perform in the coming years?
* What has been the historical performance of various hypertension therapeutic classes and how will they behave in the coming years?
* What are the leading molecules in the hypertension market and how will they behave in the coming years?
* What are the key late stage pipeline drugs and how will they perform once they are launched?

Why should you buy this Report?
* To gain an in-depth insight into the prevalence of hypertension.
* To have it as a powerful tool for identifying your target patient population.
* To facilitate business decision-making based on historical, current and forecast market data for hypertension drugs.
* To identify potential classes, drugs, partners and competitors so as to develop strategies for market penetration and drug development.
* To develop business strategies by looking at companies those have been the biggest winners and losers in the hypertension market.
* To gain an understanding into future market events and make more informed business decisions.

Research Objectives Achieved in this Report:
Evaluating the Epidemiology of Hypertension:
Key Aspects Analyzed:
* Current and future prevalence of hypertension
* Current and future size of the hypertension patient pool

Comprehensive Situation Analysis of the Hypertension Market:
Classes Covered: Antihypertensives, Angiotensin-II Antagonists, Angiotensin-II Antagonist Combinations, Calcium Antagonists, Beta-Blocking Agents, Ace Inhibitors, Ace Inhibitor Combinations and All Other Drug Classes

Key Aspects Analyzed:
* Historical, current and future market trends.
* Historical, current and future performance of various drugs.
* Historical, current and future performance of various companies.
* Product portfolio of various companies.
* Historical, current and future performance of various therapeutic classes.
* Projections for pipeline drugs.

Methodology & Information Sources:
To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K's, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.

Table of Contents
1. Research Methodology & Definitions
2. Executive Summary
3. Hypertension Prevalence & Patient Population
3.1 Prevalence of Hypertension
3.2 Hypertension Patient Pool
3.3 Diagnosed & Drug Treated Patient Pool
4. The Hypertension Drugs Market Landscape
4.1 Current Trends & Forecast
4.1.1 Current Market Trends
4.1.2 Market Forecast
4.2 Share of Various Players & Drugs
4.2.1 Current Trends
4.2.2 Market Forecast
4.3 Performance of Various Therapeutic Classes
4.3.1 Antihypertensives
4.3.1.1 Current Market Trends
4.3.1.2 Sales of Various Molecules
4.3.1.3 Sales Forecast
4.3.2 Angiotensin-II Antagonists
4.3.2.1 Current Market Trends
4.3.2.2 Sales of Various Molecules
4.3.2.3 Sales Forecast
4.3.3 Angiotensin-II Antagonist Combinations
4.3.3.1 Current Market Trends
4.3.3.2 Sales of Various Molecules
4.3.3.3 Sales Forecast
4.3.4 Calcium Antagonists
4.3.4.1 Current Market Trends
4.3.4.2 Sales of Various Molecules
4.3.4.3 Sales Forecast
4.3.5 Beta-Blocking Agents
4.3.5.1 Current Market Trends
4.3.5.2 Sales of Various Molecules
4.3.5.3 Sales Forecast
4.3.6 Ace Inhibitors
4.3.6.1 Current Market Trends
4.3.6.2 Sales of Various Molecules
4.3.6.3 Sales Forecast
4.3.7 Ace Inhibitor Combinations
4.3.7.1 Current Market Trends
4.3.7.2 Sales of Various Molecules
4.3.7.3 Sales Forecast
4.3.8 All Other Drug Classes
4.3.8.1 Current Market Trends
4.3.8.2 Sales of Various Molecules
4.3.8.3 Sales Forecast

To buy the complete report or to get a free sample:
Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe)
Email: sales@expertmarketresearch.com
To know more please visit: http://www.expertmarketresearch.com

###

Tag Words: ace inhibitor, calcium antagonists, beta blocking agents, antihypertensives

Categories: Medical

Press Release Contact
Keshav Singh
Call: +91-880-236-2536 (Asia),

Link To This Press Release:

URL HTML Code